This study is in progress, not accepting new patients
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Robin Kate Kelley
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Links
- INTR@PID Clinical Trial Program Trial Awareness and Transparency website US Medical Information website, Medical Resources
- ID
- NCT03833661
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated